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In 1949, Taylor (1)  reported the recovery from a  transformation reaction 
of a pneumococcus with a capsular  antigen which differed both from that of 
the parent of the noncapsulated Type II strain which had served  as the re- 
cipient cell and from that of the capsulated Type III strain which had served 
as the donor of deoxyribonucleates  (DNA) in the system. In 1953, Beiser and 
Hotchldss (2) described the isolation of several analogous strains of capsulated 
pneumococci from a transforming system employing the same reactants. Anti- 
sera prepared in rabbits with vaccines of these strains gave a positive capsular 
precipitin  or  QueUung reaction with homologous  cells and with other  cap- 
sulated variants recovered  from the same  transforming system which failed 
to react with Type HI or Type II anticapsular serum. DNA from these unusual 
strains was shown also to be capable  of transforming noncapsulated cells to 
the new capsular  type. Further study of the novel capsular  antigen failed to 
demonstrate a relationship between it and any of the 82 known pneumococcal 
capsular  types. In subsequent experiments  in our laboratories,  a similar  cap- 
sulated strain was recovered from a transforming reaction in which the recipient 
cells were noncapsulated variants of pneumococcus Type H; but, on this occa- 
sion, the DNA employed was extracted from capsulated Type I pneumococcal 
cells. Two hypotheses might account for the observations  described.  Uptake 
of foreign DNA might lead to recombination with or to rearrangement of resi- 
dent DNA leading to the appearance  of the novel capsular  material; or the 
cells  of  the  unusual capsular  type might be  spontaneous mutants selected 
during growth of cells in the transforming system. The experiments  to be re- 
ported support the latter hypothesis and suggest that the novel capsule, com- 
posed  of a  C-like polysaccharide,  may arise  as a  result of alteration of the 
normal mechanisms controlling the production of pneumococcal C or cell wall 
polysaccharide. 
1385 1386  PNEIY~OCOCCAL  CS POLYSACCHARIDE 
Materials and Methods 
Nomendaure  of Pnzumococcal Varients.--The  nomenclature of  pneumococcal variants 
employed will be that  described in earlier publications (3-5).  Mutants of  noncapsulated 
variants producing capsules of C-like polysaccharide will be designated by the symbols de- 
noting the parental noncapsulated strain followed by the symbol Cs; i.e., S-nC, is a variant 
of a noncapsulated strain of pneumoeoccns Type II which produces a capsule of soluble C- 
like polysaccharide. Binary and ternary capsulated strains having capsular components of 
Ca polysaccharide will be indicated in the following fashion: S-InC,SI-I11  is a ternary capsu- 
lated pneumococam producing soluble capsular polysaccharides  of Types C8, I  and 11I, the 
cell producing these polysaccharides  having been derived from a  noncapsulated mutant of 
pneumococcus Type HI. 
To indicate transformants, the letter T will be interposed between the designation of the 
parental strain and the character transformed; e.g., strain S-IIIsTCB is a noncapsulated mu- 
tant of pneumococcus Type III which has been tramformcd to capsular type Cm. 
Strains of Pneumococcus.--Noncapsulated  variants derived from several capsular types of 
pneumococcus were used. 
S-I phetw#ypes: S-it and S-I2 are described in reference 4. S-I~ is a noncapsulated mutant 
of the Type I pneumococcal strain SVI designated previously as strain I  192R. 
S-H phenotypes: The noncapsulated variants of pneumococcus Type II employed were 
all sublines of a noncapsulated mutant, R36, of strain IID39S and are described in reference 5. 
S-Hr phenotypes: The ori.ff~m of strain S-ill, is given in reference 3, that of strains S-III5 
and S-ni6 in reference 5. 
S-v phenotype: This strain is described  in reference  5. 
S-viii fil~notypes: S-viii  t is strain VIIIR1H and S-viii  2 is strain VI11R13 described in 
reference 6. 
Strain S-IICa was obtained from Beiser and Hotchkiss  (2)  and was  designated strain 
T15BM by them. 
S-i~Cs, S-isCs, S-IIIiCB, S-yes, S-viixiCs, and S-viix2Cs: spontaneous mutantsof strains 
S-Iv S-iv S-niv S-v, S-vnit, and S-vill~ producing capsules of soluble C-likepolysaccharide. 
Strains SI, SII, SIH, and SVIII are capsulated strains of pneumococcns Types I  (SVI), 
II (D39S),  I11 (A66),  and VIII (]3) described  in referenee  7. Strains SXVI,  SXXVII, and 
SXX'VlII were isolated from patients with pneumonia. 
Med/a.--All strains were  grown in beef heart  infusion broth with  Neopeptone  (Difco 
Laboratories, Detroit, Mich.). 
Isolation of Pneumococ,  cal Varla*as Producing C~ Capsular Polysaccharide.~Noncapsulated 
variants of pneumococci were inoculated into 100 ml cultures of beef heart infusion broth 
with Neopeptone to which had been added 5% human plasma and 0.1 #g/ml of purified 
pneumococcal C polysaccharide. The culture was incubated at 37°C overnight and 5 ml of 
the supernatant fluid was centrifuged 5 rain at 1000 rpm to precipitate small aggregates  of 
agglutinated noncapsulated cells. The supematant fluid of the 5 ml aliquot was used then to 
inoculate a second 100 ml culture. Variants producing Cs capsular polysaccharide were re- 
covered usually after three passages of the type described. When noncapsulated strains with a 
high back mutation rate to parental capsular type were employed, antiserum to the homolo- 
gous parental capsular antigen was included in the system. 
Preparalion of DNA  and  Techniques of Transformaion.--The  methods used were those 
described by MacLeod and Krauss (8) and by Bernheimer, Wermundsen, and Austrian (5). 
Preparation of Anticapsular Sera.--Vaccines  were made by the method described in refer- 
ence 3. 
Rabbits were immunized by intravenous injection of 1 ml of vaccine containing 50-200 BORNSTEIN, SCHLFFMAN, BERNHEIMER, AND AUSTRIAN  1387 
gg of bacterial nitrogen four times a week for 2 wk and bled 6 days after the final injection of 
vaccine. This schedule of immunization was repeated until potent antisera were obtained. 
Isolation of Filamentous Variants of Pneumococcus Producing C8 Capsular Polysaccharide.-- 
The technique employed is described in reference 7. 
Determination of M  Protein in Pneumococcal C, Capsular Variants.--The methods used 
for the preparation and absorption of antisera and for the extraction of M protein from pneu- 
mocoeeal cells are set forth in reference 6. 
Preparation of C-Reactive Protein.---C-reactive protein was isolated from pleural or ascitic 
fluids of patients with neoplastic or inflammatory disease following  precipitation of the protein 
with  Cx polysacchaxide prepared by the method of Anderson and McCarty (9). The pre- 
cipitate was washed with iced normal saline containing 5 meq/liter of calcium chloride, re- 
solubilized in 0.1 s  sodium citrate and reprecipitated by dialysis against saline with calcium. 
After several reprecipitations, the precipitate was solubilized in citrate and was resolved by 
TABLE I 
Agglutination of Pneumococcal Strain S-IIC$ by Homologous Antiserum before and after Ab- 
sorption  with Noncapsulated Pneumococci or with Homologous Cs Polysaccharide 
Serum 
Anti-S-11C~ 
Anti-S-tiCs absorbed 
with strain S-iz 
.~nfi-S-ixC.  absorbed 
with strain S-m, 
Anti-Sn:C,  absorbed! 
with C~ polysac- 
charide 
1:20 
++++ 
4- 
++ 
++ 
Antiserum  dilution 
1:40 
++++ 
J 
++ 
++ 
1:80 
+++ 
4- 
-4- 
1:160  1:320 
++  + 
1:640  1:1280 
+  ± 
1:2560 
Saline 
cont,: 
chromatography on DEAE-Sephadex A-50 in excess citrate. The final product was found to 
be free of detectable polysaccharide or of any contaminating serum proteins by immuno- 
diffusion and by immunoeleetrophoresis.  Over 85% of the total nitrogen was precipitable with 
C polysaccharide. Immunization of rabbits with such purified preparations  yielded mono- 
specific antisera to a human C-reactive protein, producing only one band of identity with all 
purified samples of CRP tested, and giving no reaction with normal human serum. 
EXPERIM-ENTAL 
Serologic  Evidence for  the Relation of the Capsular Antigen of Pneumococcal 
C, Variants to Pneumococcal  C Polysaccharide.--Rabbits were immunized with 
a vaccine of pneumococcal strain S-:xC8 to obtain potent antiserum to the cap- 
sular  antigen of  this  strain. To render  such  antiserum type  specific,  it was 
absorbed  with  a  vaccine  of  pneumococcus  S-:I  to  eliminate antibodies  to 
other pneumococcal constituents. Following such treatment, the antiserum no 
longer agglutinated the  cells of  the vaccine strain S-:~CB,  used to immunize 
rabbits (Table I)  and failed to give a  positive capsular precipitin reaction as 1388  PNEUMOCOCCAL  CS POLYSACCHARIDE 
it had prior to treatment. Absorption of the same antiserum with an heterol- 
ogous  strain  of noncapsulated pneumococci, S-m,,  was followed by similar 
results.  The findings suggested strongly that  the capsular  antigen of strain 
S-~IC, was related to a somatic antigen common to pneumococci derived from a 
variety of capsular types. A purified preparation of pneumococcal C  polysac- 
charide  was  prepared  (10),  therefore;  and  the  antiserum  to  pneumococcus 
S-uC, was absorbed with this material. The results of this experiment were 
the same as those following absorption of the antiserum with vaccines of intact 
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Fro. 1. Precipitation of pneumococcal C polysaccharide  by antiserum to strain S-HCa. 
Precipitin curves obtained by adding C polysacehaxide  to antiserum before (A  A) and 
after (A  A) absorption  with homologous  C8 polysaccharide. 100/zl of unabsorbed serum 
and 500 #1 of absorbed serum were used. 
noncapsulated pneumococci. Precipitation of C  polysaccharide by antiserum 
to pneumococcus S-IIC, before and after absorption with C polysaccharide is 
shown in Fig. 1. 
Antisera prepared by prolonged immunization of rabbits with noncapsulated 
pneumococcal strains  S-II  and  S-m,  reacted with cells  of strain S-x~Cs in  a 
fashion consistent with the findings noted in the preceding paragraph although 
sera from these rabbits were totally unreactive prior to immunization. Anti- 
sera to these two noncapsulated strains agglutinated strain S-uC, (Table II) 
and each  gave a  positive  capsular  precipitin  or  QueUung  reaction with the 
cells of strain S-uC~ • 
Capsular polysaccharide of strain S-re, C,, which produces a  larger capsule BORNSTEIN,  SCHI~FMAN, BERNHEIMER, AND AUSTRIAN  1389 
than strain  S-nC,, was isolated from the supernatant fluid d  cultures of the 
organism by precipitation  with 1 volume of ethanol. No C polysaccharidc is 
precipitated  from supematant fluids  of cultures  of noncapsuiated pneumococci 
by this  technique. Absorption of antisera  to strains  S-II,  S-m4, and S-In,C, 
with the capsular polysaccharide of strain  S-m4C~ obtained in this  fashion re- 
TABLE II 
Agglutination  of Pneumococcal Strain  S-HCs  by  Antisera  to  Noncapsulated  Pneumococci 
Serum 
1:20 
Anti-S-if  + + + 
Anti-S-hi  4  +++ 
Antiserum dilution 
Ssline 
control 
......  1:40  1:80  1:160  1:320  1:640  1:1280  1:2560 
++  i  +  1  +  i  4-  i  -  i  -  - 
+++[ ++[ ++[  +14-1 
N 
TABLE III 
Effect of Absorption of Antisera  to Pneumococcal Strains  S-rtz Cs, S-Hz  4, and S-tr with the 
Capsular Polysaccharlde of Strain S-zrt4Cs on Their Ability to Agglutinate Cells of Strain 
S-zrr4Cs 
Antiserum 
knti-S-m4C, 
etnti-S-in6C  m  ab- 
sorbed with C, 
polysaccharide 
knti-S-m  4 
~nti-S-m4 ab- 
sorbed with C, 
polysaccharide 
~mti-S-n 
kuti-S-n absorbed 
with C. poly- 
sacchaxide 
1:20 
i++++ 
4- 
+++ 
++ 
+++ 
4- 
Antiserum dilution 
1:40 
++++ 
4- 
+++ 
4- 
+++ 
1:80 
++++ 
+++ 
++ 
1:160 
++++ 
++ 
+ 
1:320 
+++ 
++ 
4- 
I:~0  1:1280 1:2560 
++  +  - 
+  - 
Saline 
control 
suited in loss of the ability of all three antisera to agglutinate strain S-ui4Cs 
(Table HI). Loss of the ability of antisera to strains S-IICs and strain S-iu~ to 
precipitate  C  polysaccharide  following  absorption  with  the  capsular  poly- 
saccharide of strain S-uCs obtained in the same fashion is shown in Fig. 2. 
The foregoing findings  are  all consistent with  the  conclusion that  the  Cs 
polysaccharide of these strains is related very closely to the C or cell wall poly- 
saccharide of pneumococcus. Biochemical evidence of the close similarity of C 
and C~ polysaccharides will be presented in a subsequent report. 1390  PIW~UMOCOCCAL  CS  POLYSACCHARIDF. 
Reaction  of  Pneumococcal  C~  Variants  with  Human  C-Reactive Protein 
(CRP).--The serologic evidence indicative of similarity between the C and C, 
polysaceharides suggested investigation of the reactivity of ceils of pneumococ- 
cus S-~C~ with CRP. Microscopic examination of these cells mixed with CRP 
showed a  positive capsular precipitin or Quellung reaction in the presence of 
calcium ions but not in the absence of the latter. The refractile properties of 
the  capsule were indistinguishable  from those obtained in  the reaction with 
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FIG. 2.  Precipitation of pneumococcal C polysaccharide by antisera to noncapsulated 
pneumococcal  strains S-II and S-III4 before and after absorption  with Cs polysaccharide  from 
strain S-HCs. Preeipitin curves obtained by adding C polysaccharide  to 100/~1 of anti-S-ii 
serum  ( •  I)  or to 20 #1 of anti-S-iii4  (•  •) before absorption. Curves obtained 
with 100 #1 of each antiserum after absorption with the Cs polysaccharide  of strain S-IIC8 
are shown in open squares (anti-S-ii)  and open circles (anti-S-iii4). 
type-specific antiserum.  The same preparations  of purified CRP  gave also a 
positive capsular  precipitin reaction with  cells of pneumococcal types XVI, 
XXVII,  and XXVIII  (Table IV),  confirming the  observations  of L6fstr6m 
(11). These reactions, like those with cells of strains S-IIC, and S-vmlC~, were 
calcium dependent.  Antiserum to strain  S-HC~, unlike  CRP,  failed to react 
visibly with cells of the  three other pneumococcal capsular  types cited, and 
capsular antibody to each of the same three pneumococcal types gave no reac- 
tion with cells of strain S-vmlCs. 
Cells  of  strain  S-zzC~ were  also  agglutinated  by  CRP  in  the  presence  of BORNSTEIN,  SCHIFFMAN,  BF..RNHEIMER,  AND  AUSTRIAN  1391 
calcium but not in its absence (Table V). The reaction was characterized by a 
very narrow range of agglutination by the CRP and when the standard dilu- 
tions used in agglutination tests with serum were employed, agglutination was 
observed in only 1 tube in which the CRP was diluted 1:320. When smaller 
increments of dilution were examined in this range, the phenomenom of ag- 
glutination by CRP could be demonstrated unequivocally. The agglomerates 
were distinctly more fragile than those produced by antiserum.  Similar reac- 
TABLE IV 
Capsular Precipitin Reactions of Pneumococcal Types Cs, XVI, XXVII, and XXVIII with 
CRP and with Anticapsular Sera 
Serological reagent 
Pneumococca]  strain 
CRPca  ++wlth  CRPcaW~+thout  Anfi-Cs  Anti-XVI  Anti-XXVLI  Anfi-XXVIII 
S-VIII1C  s  -~  --  ~-  --  --  -- 
s  xvI  +  -  +  -  - 
s  xxvII  +  -  -  +  - 
s XXVlII  +  -  -  -  + 
TABLE V 
Agglutination of Pneumococcal Strain S-tH4Cs by Human C-Re~ive Protein 
CRP  dilution 
Antigen  Saline control 
S-m,C. 
S-re,C. 
1:20  !  1:40 
1:200  1:240 
I  + 
1:80  i  1:160 
i 
1:280  1:320 
++l++ 
1:320  [  1:6#,0 
i-- 
+  - 
1:360  1:400 
++ 
1  1:1280  [ 1:2560 
i 
1  1:440  1:480 
+  :::t:  - 
tions were observed with bentonite particles coated with C~ polysaccharide. 
C~ polysaccharide obtained by precipitation of culture supematant  fluids of 
strain S-IzC~ with 1 volume of ethanol precipitated human CRP with the same 
efficiency as pneumococcal C  polysaccharide when calcium was present (Fig. 
3). These data also suggest the close relationship of C~ to C polysaccharide. 
Origin of (7,, Pneumococcal  Strains.--The finding that C, polysaccharide was 
related closely to the C or cell wall polysaccharide suggested that strain S-nC, 
might be a  spontaneous mutant  resulting from an  alteration in  the  genetic 
control of the amount of C polysaccharide synthesized by the cell. 
Most normal human and murine sera contain some antibody reacting with 1392  PNEUMOCOCCAL CS POLYSACCHARIDE 
pneumococcal C polysaccharide.  Because human plasma or rabbit antisera to 
noncapsulated pneumococci  are  included  in  experiments  designed  to isolate 
capsulated transformants of pneumococcus, the selection of C, capsular  vari- 
ants of pneumococcus in such experiments would appear at first to be unlikely. 
Examination of preparations of transforming DNA obtained by the methods 
employed in the experiments from which C, variants were recovered originally 
showed  them to contain 5-50  #g/ml of pneumococcal  C polysaccharide,  an 
amount sufficient to combine completely with all the anti-C antibodies present 
in most human plasmas  and rabbit antipneumococcal  sera.  Because of these 
findings,  attempts were made to isolate  C~ variants from a  variety of non- 
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FI0. 3. Precipitation of pneumococcal Cs polysaccharide (A 
C polysaccharide (0  O) by human CRP. 
A) and pneumococcal 
capsulated pneumococcal strains by growing them in broth containing human 
plasma which agglutinated them in the presence of an excess of purified pneumo- 
coccal C or Ca polysaccharide  which had been treated with DNAase.  To cul- 
tures of the noncapsulated strains S-is and S-m, which have high back muta- 
tion rates to their respective parental capsular types, antibody to the homolo- 
gous capsular  polysaccharide was added also to prevent the selection of cap- 
sulated Type I or Type III cells. 
Cs variants were isolated from populations of seven noncapsulated pneumo- 
coccal strains: S-~, S-I4, S-II ,  S-III4 ,  S-v ,  S-viii  1 , and S-vm, • The ease with 
which such mutants were recovered varied considerably from strain to strain 
and some required  multiple passage in cultures of 100 ml before the  mutant 
was isolated. 
All  Cs variants grew  diffusely in broth containing human plasma in  the 
presence or absence of added C polysaccharide, and all give a positive capsular BORNSTEIN~  SCHI~FMAN~ BERNHEIMER~  AND AUSTRIAN  1393 
precipitin reaction with antibody to strain S-HC~ • These observations  demon- 
strate  that  C. variants  of  pneumococcus  are  spontaneous mutants of  this 
organism  and that their initial discovery  in experiments  designed  to effect 
pneumococcal capsular transformation was probably a fortuitous result of the 
neutralization of antibodies to pneumococcal C polysaccharide by the C poly- 
saccharide present in the preparations of DNA employed. 
Properlies  of C, Pneumococcal  Variants.mPneumococd producing a capsule 
of C8 polysaccharide  are stable and grow diffusely in broth like other strains 
of this species. On the surface of blood agar plates, they give rise to colonies 
which differ little in morphology from those of the noncapsulated variants from 
TABLE VI 
Ink~ion of Capsulated, Noncapsulated, and Ca Pneumococsal Va~a~s by Penc~Hn G 
Parental pneumococcal  type 
SI 
SII 
SIH 
SVIII 
Minimal bactcriddal concentration of Peltlei!l|n~ w~l~ 
0.01 
~hCo 
S-n 
0.02 
SI 
S-12 
SH 
S-nC, 
SIH 
S'n  h 
S'm4C, 
SVIH 
S-w'III1Cs 
0,03 
S-vm~ 
which they are derived.  In capsular  precipitin  tests, the size d  the refractile 
halo around the cell varies from that seen in analogous reactions of pneumococ- 
cal Types I or IV with their homologous anticapsular sera to one which is just 
discernible. 
The C8 variants undergo autolysis like other pneumococcal strains and are 
solubilized in the presence of surface-acting agents such as sodium deoxycholate. 
Because of the similarity of C and C8 polysaccharide and the association of the 
former with  the  cell wall  mucopeptide  of  pneumococcus,  the  resistance  of 
several Cs variants of pneumococcus to penicillin was investigated.  The data 
are summarized in Table VI and demonstrate no increase in resistance  of the 
Cs variants to the antibiotic over that of the noncapsulated strains from which 
they were derived. 
Because of the close similarity of the Cs capsular  material to the C or cell 
wall polysaccharide  of pneumococcus, experiments  were carried  out to deter- 1394  PNEU~OCOCCAL  CS POLYSACCHAR]I)E 
mine whether or not alteration in the mode of cellular separation after division 
would be accompanied by any change in the expression of the C, capsule. All 
spontaneous mutants of pneumococcus  bearing  the C, capsule  were isolated 
originally  as  nonfilamentous variants.  Cells  of  two  strains,  S-m~Ca and 
S-vmlC,, were plated by the technique described earlier (7) for the isolation 
of filamentous variants of pneumococcus. Mter two to three transfers on solid 
media, colonies of each strain gave rise to marginal excrescences composed of 
filamentous cells which, in Gram-stained preparations,  differed in no way from 
filamentous strains of pneumococcus described previously. Examination of the 
cells comprising the excrescences by the capsular  precipitin or Quellung reac- 
tion showed the cells still to be producing capsules of Ca polysaccharide. DNA 
was prepared from cultures derived from single filamentous clones of strains 
S-Iu,Ca  and S-vm, C,.  The  preparations were capable  of transforming non- 
filamentous  noncapsulated  pneumococci to either the filamentous  noncapsu- 
lated genotype or to  the nonfilamentous  Ca capsulated genotype.  From these 
observations,  it would  appear that there is no relation between  the mode of 
pneumococcal  cellular  separation  after  division  and  the  production  of  C, 
capsular polysaccharide. 
Pneumococeal C, variants derived  from strains S-~ and S-m, were examined 
for the presence of M protein. Strain S-~Ca carries M protein type 2', and strain 
S-m~Ca carries  M  protein type 3 (Fig.  4 a-4 d). The production of Ca poly- 
saccharide  is not  accompanied by any striking qualitative change in the pro- 
duction of this somatic antigen. 
Occurrence of C, Pneumococcal Variants in Nature.--The occurrence in man 
of pneumococcal Ca capsular variants cannot be assessed with certainty at the 
present time.  Microscopic  examination of spreads  of 500  sputum specimens 
from patients with acute or chronic respiratory disease by the capsular precipi- 
tin or QueUung technique has shown one to contain rare coccal forms giving an 
unequivocally positive reaction.  Unfortunately, this organism could not be re- 
covered from cultures of the same sputum specimen made at the same time as 
the preparation for microscopy. In any event, pneumococcal C~ variants appear 
not to be common inhabitants of the human respiratory tract. 
Virulence of Ca Pneumococcal Variants.--Pneumococci  with capsules  of Ca 
polysaccharide  are lacking in virulence for several species of rodents.  Injection 
of 1 ml of undiluted culture of strain S-t, Ca intraperitoneally or subcutaneously 
into rats, guinea pigs, or rabbits failed to produce death or progressive localized 
lesions. Occasional deaths occurred in mice following injection of 1 ml of un- 
diluted culture of strains S-m4C, or S-vmlC,, both of which have capsules of 
moderate size. 
Phagocytosis of C8 Pneumococci by Human Polymorpkonuclear Leukocytes.-- 
Because of the lack of virulence of C~ pneumococcal variants for several species 
of laboratory animals, their phagocytosis by human polymorphonuclear  leuko- BORNSTEIN,  SCHIFFMAIq~ BERNHEIMER,  AND  AUSTRIAN  1395 
FIG. 4.  a.  Center well,  anti-M2' serum  (unabsorbed); wells A  and C,  extracts of strain 
S-nCs; well B, extract of strain S-ix; well D, C polysaccharide; and well E, extract of strain 
S-in4Cs. b. Center well, anti-M2' serum absorbed with strain S-ni4. Outer wells as in 4 a. 
c. Center well,  anti-M3 serum (unabsorbed); well A, extract of strain S-III~Cs; well B, ex- 
tract of strain S-IIT4 ; well C, extract of strain S-IICs; well D, C polysaccharide; and well E, 
pepsin-treated extract of,strain S-III4Cs. d. Center well, anti-M3 serum absorbed with strain 
S- n. Outer wells as in Fig. 4 c. 1396  PNEUMOCOCCAL  CS  POLYSACCHARIDE 
cytes was investigated. 0.3 ml of fresh venous blood from a normal human sub- 
ject  containing 6.6  units of  heparin was mixed with 0.2  ml of  pneumococcal 
culture to give a ratio of l0 bacterial infectious centers per polymorphonuclear 
leukocyte. To separate tubes of the mixture, 0.1  ml of sterile physiologic salt 
solution, of a  solution of Cs polysaccharide containing 50 ~g/ml or of C, anti- 
TABLE VII 
Phagocytosis of Capsulated, Noncabsulated,  and  C.~ Pneumococcal  Variants  by Human Poly- 
morphonuclear Leukoc Jtes 
Pneumococcal 
variant 
SVIII 
S-VIII 1 
Incuba  tion 
time 
#nir~ 
10 
10 
30 
30 
10 
10 
10 
10 
10 
10 
30 
30 
30 
30 
Cs poly- 
Antibody N  saccharide 
,ug/ml  #g/ml 
0  0 
10  0 
Anti-SVIII 
0  0 
10  0 
Anti-SVIII 
0  0 
0  8 
0  0 
0  8 
0  160 
160  0 
Anti-C.. 
0  0 
0  8 
0  160 
160  0 
Anti-C~ 
S-vJlitCs 
Organisms ingested per polymorphonuclear 
leukocyte 
0  [  1-3 
l 
i 
97  3 
30  18 
100 
10 
16  46 
17  46 
0  10 
13  50 
26  34 
4  14 
4--6 
0 
17 
0 
22 
19 
24 
29 
31 
26 
40 
10 
23 
5 
6 
7-9  104- 
0  0 
18  17 
0  0 
20  44 
15  4 
8  5 
32  29 
3  3 
11  3 
26  16 
28  58 
33  37 
23  64 
10  78 
serum was added. The tubes were sampled at zero time and at indicated inter- 
vals during incubation at 37°C in a roller drum. The samples were smeared on 
cover slips, stained with Wright's stain, and the  bacteria in  100  polymorpho- 
nuclear leukocytes counted. 
The results of experiments with  pneumococcal strains  SVIII, S-VIII1  ,  and 
S-vmlC, are  shown in Table VII.  In contrast  to  the  capsulated Type VIII 
strain which was not phagocytized in the absence of added anticapsular anti- 
body, cells of  strains S-vT,I1 and S-viii1Cs  were  ingested rapidly by the poly- BORNSTEIN, SCHIF]~MAN, BERNHEIMER, AND AUSTRIAN  1397 
morphonuclear leukocytes in normal human blood. Because the serum of the 
donor of the blood used in this experiment contained 1-2 ttg/ml of antibody N 
to pneumococcal C polysaccharide, the effect on phagocytosis of neutralization 
of this  small  amount  of antibody with C8 polysaccharide was examined.  As 
shown in Table VII, the neutralization of anti-C antibody resulted in a meas- 
urable slowing of phagocytosis of the C8 variant; whereas it had little effect, if 
any, on the phagocytosis of cells of the noncapsulated strain from which the 
C~ variant  arose.  The findings  indicate  that,  although  antibody accelerates 
slightly the phagocytosis of C~ pneumococcal cells, it is not essential to their 
ingestion by human polymorphonuclear leukocytes. 
Genetic Studies  of  C~ Pneumococcal Variants.mDNA  of  C~  pneumococcal 
strains transforms readily competent noncapsulated variants  of pneumococci 
derived from strains of several capsular types (Types I, II, III, and VIII) to 
the C, genotype in the transforming systems cited in the section on Materials 
and Methods. 
In an experiment in which DNA of the capsulated strain S-m4C, was used 
to transform cells of the noncapsulated strain S-ms, two capsulated variants 
were recovered, Type III cells and  C, ceils. It is known from earlier  experi- 
ments that strains S-m4 and S-ms both possess the capsular genome of pneumo- 
coccus Type HI with mutations at different sites in the cistron controlling the 
synthesis of uridine diphosphoglucose dehydrogenase (4). When either strain is 
transformed with the DNA of the other,  genetic recombination leads to cor- 
rection of the defect in the synthesis of Type III capsular polysaccharide and 
fully capsulated Type III pneumococci are recovered. Additional studies of the 
genes controlling normal capsular synthesis have shown that they occupy the 
same region of the pneumococcal chromosome regardless of capsular type (4). 
In the present experiment, in which transformation of strain S-ms with DNA of 
strain  S-m4C,  led to the recovery of both capsulated Type IlI cells and  C, 
cells, it is apparent that the genetic locus responsible for the production of C, 
capsular  polysaccharide must  occupy a  site  other  than  that  controlling  the 
synthesis of other pneumococcal capsular polysaccharides. 
Further  evidence for the foregoing  conclusion  has been obtained in trans- 
formation reactions in which binary and ternary capsular variants of pneumo- 
coccus have been isolated, one of the capsular components being C. polysac- 
charide.  These experiments were carried out with the technique described in 
reference 5 because C. variants  proved refractory  to  transformation  in  the 
transforming system described by MacLeod and Krauss (8). When pneumococ- 
cal strain S-m6TC, was exposed to the DNA of an intermediate capsular variant 
of pneumococcus Type III,  S-HT SIII~, the binary capsulated strain, S-meTC. 
Sill, which produced both C, polysaccharide and normal amounts of Type III 
polysaccharide, was recovered. When the same recipient strain S-m6TC, was 
exposed to DNA of a streptomycin-resistant pneumococcus carrying the wild 1398  PNEIYMOCOCCAL  CS POLYSACCIIARIDE 
Type I  pneumococcal capsular genome,  transformation  of the streptomycin 
marker was observed, but no new capsular phenotypes were isolated.  If DNA 
from  a  streptomycin-resistant  strain  carrying  an  atypical  Type  I  capsular 
genome  (5)  was used, however, ternary capsular cells were recovered which 
produce Ca, Type I  and Type III capsular polysaccharides and which give a 
positive capsular  precipitin  or Quellung reaction with specific Type I,  Type 
III,  and  Ca capsular antisera.  These experiments show conclusively that  the 
genes controlling  the synthesis of soluble Cs polysaccharide can exist in pneumo- 
cocci producing one or two normal capsular polysaccharides and must occupy a 
position in the pneumococcal genome distinct from those controlling  the latter. 
DISCUSSION 
The experiments described demonstrate that  the novel capsular variant  of 
pneumococcus isolated during the course of transformation reactions by Taylor 
(1) and by Beiser and Hotchkiss (2) was not the product of interaction between 
transforming DNA and the cells exposed to it but rather a  spontaneous mu- 
tant. Recognition of the immunologic relatedness of the capsular polysaccharide 
of this mutant to pneumococcal C or cell wall polysaccharide has permitted the 
use of an appropriate selective  environment to obtain similar  mutants from a 
variety of noncapsulated pneumococcal strains derived from several capsular 
types in the absence of exogenous DNA. The demonstration of C polysaccharide 
in preparations of transforming DNA explains  also why the Ca mutants were 
selected in the transforming systems from which they were first isolated. The 
chemical  constitution  of the  Ca  capsular  polysaccharide  is very similar  to 
though not identical with, that of pneumococcal C polysaccharide, as antici- 
pated from immunologic  findings, and will be presented subsequently in greater 
detail. 
Further evidence for the relatedness of Ca polysaccharide to pneumococcal C 
polysaccharide has been derived from  the reactivity of the former with  C- 
reactive protein.  The capsular precipitin  or Quellung  reaction resulting  from 
the interaction of pneumococcal cells producing capsules of Cs polysaccharide 
with CRP in the presence, but not in the absence of calcium ions adds another 
pneumococcal variant  to  the  three  manifesting  this  phenomenon  described 
earlier by L6fstrtim (11). Comparison of the chemical structures of the capsular 
polysaccharides of pneumococcM Types XVI, XXVII, and XXVIII with those 
of  C  and  Ca  polysaccharides may help  elucidate  further  the nature  of  the 
chemical groups reacting with CRP. In the light of the observations of Gotsch- 
lich and Edelman (12), it is of interest that the three capsular polysaccharides 
reacting with CRP are believed to contain phosphate in their structures (13). 
Genetic analysis of Ca pneumococcal variants  has shown dearly that  the 
genetic factor controlling  the synthesis of soluble capsular Cs polysaccharide is 
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identified capsular polysaccharides of pneumococcus. This fact has permitted 
the isolation of binary capsulated pneumococci,  one of the capsular components 
of which is Ca polysaccharide. It has permitted also for the first time, the isola- 
tion, following transformation, of ternary capsulated strains of the same species. 
The precise nature of the mutation leading  to the production of soluble C, 
capsular polysaccharide has not been defined. Several hypothetical possibilities 
exist.  Production of Cs polysaccharide might  result from derepression  of the 
control mechanism for the synthesis of C polysaccharide, from gene duplication 
or from a genetic alteration affecting  the linkage  of C polysaccharide to other 
cell wall constituents. Information currently available does not permit distinc- 
tion among these three possibilities.  Production of capsular material related to 
structural  cell  wall  polysaccharides  has  not  been  a  commonly  recognized 
phenomenon in bacteria.  The  observations of Knox and  Hall  (14)  in Lac/o- 
bacillus  casei var. rhamnosus describe a possible mechanism for capsule forma- 
tion resulting from a disturbance of the coupling  of cell wall polysaccharide to 
other cell wall constituents. 
Whether or not C, pneumococcal variants occur in nature is uncertain at the 
present time. It is conceivable that they might have very limited potential for 
survival over noncapsulated variants  of pneumococcus but the difference  in 
susceptibility to phagocytosis between C, and noncapsulated variants is not 
marked. The availability of a potent serologic reagent which gives a positive 
capsular precipitin or Quellung  reaction with C~ pneumococcal cells, however, 
makes feasible  a  continued  search  for such forms in mammalian  secretions. 
Such sera provide also the most potent immunologic  reagents for the detection 
of pneumococcal C polysaccharide in extracts of this organism and for the de- 
tection of cross-reacting  polysaccharides in other strains  of streptococci from 
the human respiratory tract (15). 
SUMMARY 
Capsulated mutants of pneumococcus producing a  capsule of soluble poly- 
saccharide  related  immunologically to  the  C  or  cell  wall  polysaccharide  of 
pneumococcus have been isolated from several noncapsulated variants of this 
organism.  The capsular material of these strains reacts with antisera both to 
homologous strains  and  to noncapsulated strains  of pneumococcus and with 
human C-reactive protein. C-reactive protein has been shown to give a positive 
capsular precipitin or Quellung reaction with C, pneumococcal variants and to 
agglutinate them. 
The genetic locus which determines the production of Cs polysaccharide is 
situated in a region  of the pneumococcal chromosome distinct from that con- 
trolling  normal capsular polysaccharide synthesis. Binary and ternary capsu- 
lated pneumococci,  one of the capsular  components of which is Cs polysac- 
charide,  have been isolated following DNA-mediated transformation. 1400  PNE~OCOCCAL  CS POLYSACCHARLDE 
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